GLICEFAR® Injectable solution

Central muscle relaxant

Adjuvant for the induction of anesthesia in horses.
It can be used as an inducing agent in combination with barbiturates to soften the stage of induction and recovery of the latter.
It can also be used in a combination with other agents such as Xylazine and Ketamine, to maintain anesthesia and thus decrease the concentration of inhalation anesthesia.
Its use is recommended only in adult horses.

Technical Specification

Species

Horses.

Dosage form

Injectable solution.

Therapeutic action

Central muscle relaxant

Composition

Each mL of product contains:               
Guaifenesin......................100 mg
Excipients q.s.p.....................1 mL

Indications

Adjuvant for the induction of anesthesia in horses.
It can be used as an inducing agent in combination with barbiturates to soften the stage of induction and recovery of the latter.
It can also be used in a combination with other agents such as Xylazine and Ketamine, to maintain anesthesia and thus decrease the concentration of inhalation anesthesia.
Its use is recommended only in adult horses.

Use instructions

  • To use in combination with barbiturates, add the barbiturate (example: Thiopental) dose to the Glicefar® solution before the administration and proceed to the infusion or administer it as a bolus immediately after the administration of Glicefar®.
  • To use in combination with xylazine and/or ketamine, Xylazine is administered 2 to 5 minutes before the administration of Glicefar® in the recommended dose and later the ketamine will be administered, once the ataxia signs from Glicefar® are present.   

Route od administration and dosage

Intravenous administration only.

Recommended dose: 100 - 110 mg / Kg
Recommended practical dose: 1 mL / Kg of weight.

Contraindications

Do not administer to pregnant or lactating females.

Special precautions for use

  • The extravascular injection should be avoided as it can cause irritation of the tissue.  
  • It is recommended to monitor the heart and breeding rate of the patient when administering Guaifenesin (Glyceryl Guaiacolate).          

Special precautions for the operator

  • Guaifenesin (Glyceryl Guaiacolate) is irritant to skin and mucous membranes, for that reason people should avoid any direct contact or accidental ingestion. The use of disposable gloves is recommended when handling this product.        
  • Wash hands after using the product.                  
  • Guaifenesin (Glyceryl Guaiacolate) may cause hypersensitivity reactions. 

Antidote

There is not specific antidote.

Warnings

Keep out of reach of children.

Adverse effects

Symptoms of breeding apnea, nystagmus, hypotension and stiff muscles are associated with toxic drug levels.
One liter of the product can be administered without showing toxic effects in the individual.

Guard period

Do not use in horses which meat is intended for human consumption.

Conservation

Store in a cool and dry place, between 15° and 30°C, protected from sunlight.   

Condition of sale

To be supply only on veterinary prescription. 

Presentation

serum container with 500 mL

Prepared by

Drag Pharma Laboratory.

Records

Reg. SAG No. 2039
Costa Rica: Reg. N° MAG CL 4-3-11-6176
Perú: Reg. SENASA F.A0.01.I.0004


Countries where it is marketed

Imported and Distributed by Representaciones Durand SAC.
Av. Manuel Olguín No. 501 Office No. 604 Santiago de Surco Lima.

You have entered drug info or veterinary products intended exclusively (s) kind (s) indicated (s).

Drag Pharma Lab is not responsible for the consequences of misuse of the products, and the use of this information without consulting a veterinarian